Back to Search
Start Over
Relationship of Red Cell Distribution Width to Adverse Outcomes in Adults With Congenital Heart Disease (from the Boston Adult Congenital Heart Biobank)
- Source :
- The American journal of cardiology. 122(9)
- Publication Year :
- 2018
-
Abstract
- Red cell distribution width (RDW), a measure of variability in red cell size, predicts adverse outcomes in acquired causes of heart failure. We examined the relation of RDW and outcomes in adults with congenital heart disease. We performed a prospective cohort study on 696 ambulatory patients ≥18years old enrolled in the Boston Adult Congenital Heart Disease Biobank between 2012 and 2016 (mean age 38.7 ± 13.5 years; 49.9% women). The combined outcome was all-cause mortality or nonelective cardiovascular hospitalization. Most patients had moderately or severely complex congenital heart disease (42.5% and 38.5%, respectively). Mean RDW was 14.0 ± 1.3%. RDW15% was present in 81 patients (11.6%). After median 767days of follow-up, 115 patients sustained the primary combined outcome, including 31 who died. Higher RDW predicted both the combined outcome (hazard ratio [HR] for RDW15% = 4.5, 95% confidence interval [CI] 3.0 to 6.6; HR per + 1SD RDW = 1.8, 95% CI 1.6 to 2.0, both p0.0001) and death alone (HR for RDW15% = 7.1, 95% CI 3.5 to 14.4; HR per + 1SD RDW = 1.8, 95% CI 1.6 to 2.0, both p0.0001). RDW remained an independent predictor of the combined outcome after adjusting for age, cyanosis, congenital heart disease complexity, ventricular systolic function, New York Heart Association functional class, hemoglobin concentration, mean corpuscular volume, high-sensitivity C-reactive protein and estimated glomerular filtration rate (HR per + 1SD RDW = 1.5, 95% CI 1.2 to 1.9, p0.0001). RDW also remained an independent predictor of mortality alone after adjustment for age plus each variable individually. In conclusion, elevated RDW is an independent predictor of all-cause mortality or nonelective cardiovascular hospitalization in adults with congenital heart disease. This simple clinical biomarker identifies increased risk for adverse events even among patients with preserved functional status.
- Subjects :
- Adult
Erythrocyte Indices
Heart Defects, Congenital
Male
medicine.medical_specialty
Heart disease
030204 cardiovascular system & hematology
Severity of Illness Index
Cohort Studies
03 medical and health sciences
0302 clinical medicine
Oxygen Consumption
Internal medicine
medicine
Humans
030212 general & internal medicine
Prospective cohort study
Heart Failure
business.industry
Hazard ratio
Red blood cell distribution width
Arrhythmias, Cardiac
medicine.disease
Confidence interval
Hospitalization
Heart failure
Ambulatory
Cardiology
Exercise Test
Female
Cardiology and Cardiovascular Medicine
business
Pulmonary Ventilation
Biomarkers
Cohort study
Boston
Subjects
Details
- ISSN :
- 18791913
- Volume :
- 122
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- The American journal of cardiology
- Accession number :
- edsair.doi.dedup.....7757ce24ec9c7b812bf62303944c979f